Public Testimonies at FDA-SSRI-Suicidality Hearings, Dec. 13, 2006

Only if one assumes that the FDA sees the drug industry as its client can some sense be made of December 13th meeting of the FDA’s Psychopharmacologic Drugs Advisory Committee in Silver Springs, Maryland.

Continue reading →

Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearings

The question is: will Eli Lilly succeed, once again, to divert public attention from the revelations contained in its internal documents about the company's illegal marketing practices and its failure to warn about lethal risks posed by its product?

Continue reading →